Marketing Recommendations From a marketing and media perspective, its important to understand that although GLP-1 usage is on the rise and represents a large part of the overall adult population, it is still only one segment of the US adult population
Rather than rejecting these reports with the a priori assumption that they are scientifically unsound, we believe that some investigation into these claims is in order
And already, as CNN recently reported, a whopping 1.7 percent of Americans, or roughly 5.68 million people, have been prescribed semaglutide drugs in 2023, though its likely that far less of them are actually taking it because of a massive months-long shortage
The startup obtained worldwide rights to develop GLP-1 as a metabolic therapy from a group of those researchers, based at Massachusetts General Hospital
A licensed, state-credentialed physician examines your online health assessment and writes a prescription only when the treatment is medically suitable for your situation
